公司资料

Intuitive 股价、新闻与催化剂

股票代码:
ISRG
交易所:
NASDAQ
行业:
Biopharma
所在地:
Sunnyvale, California

股票表现

390.33 USD (-1.06%)

收盘价

最后更新: 2026年8月17日

142B USD

市值

股价为何变动

As of Aug 17, 2026, ISRG closed down 1.06% at $390.33. No new same-company headline was identified in the current news window.

公司概览

Robotic-Assisted Surgery

Intuitive is a medical-technology company that pioneered robotic-assisted minimally invasive surgery. Its business combines capital systems, instruments, accessories, service and training across a large installed base.

Da Vinci Platform

The da Vinci surgical system enables surgeons to perform procedures through small incisions using articulated instruments and high-definition visualization. Da Vinci 5 is the newest generation and expands computing, sensing and ergonomic capabilities.

Ion Endoluminal System

Ion is a robotic platform for minimally invasive lung biopsy. Its flexible catheter and navigation technology allow clinicians to reach small peripheral pulmonary nodules for tissue acquisition.

Procedure-Driven Business Model

System placements expand Intuitive’s installed base, while each procedure generates recurring instrument and accessory demand. Service contracts, training and clinical support deepen hospital relationships and reinforce platform adoption.

未来催化剂

  • Intuitive Surgical is still a da Vinci story, with the market focused on procedure growth, da Vinci 5 rollout, and installed-base monetization. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.

近期新闻

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

相似股票

商业成熟度、治疗领域或催化剂模式相近的同行公司。